Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • A systems approach leading to an integrated and automated workflow solution for screening of monoclonal antibody hybridomas
screening monoclonal antibody hybridomas
Application Note

A systems approach leading to an integrated and automated workflow solution for screening of monoclonal antibody hybridomas

Unlock the potential of monoclonal antibody screening with our cutting-edge integrated automated workflow solution. This innovative approach combines automated liquid handling, advanced assay reagents, and sophisticated detection and analysis software to streamline the screening process. Experience enhanced reproducibility, increased efficiency, and scalability across various discovery platforms.
 

Key features:

  • Automated liquid handling: ensures precise reagent dispensing with the JANUS™ workstation
  • High-throughput screening: utilizes the EnVision™ multimode plate reader for superior sensitivity
  • Flexible data analysis: MyAssays™ software offers customizable and user-friendly analysis
  • Enhanced reproducibility: automation minimizes human error for consistent results.
  • Increased efficiency: streamlined workflows reduce assay time and labor costs
  • Scalability: adaptable to various monoclonal antibody discovery platforms.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Download Resource

A systems approach leading to an integrated and automated workflow solution for screening of monoclonal antibody hybridomas

Download Application Note
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.